Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Pasireotide 10mg inj vials
0803043Q0AAAGAG
|
Pasireotide | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Pasireotide 20mg inj vials
0803043Q0AAADAD
|
Pasireotide | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Pasireotide 300micrograms/1ml inj ampoules
0803043Q0AAAAAA
|
Pasireotide | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Pasireotide 30mg inj vials
0803043Q0AAAHAH
|
Pasireotide | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Pasireotide 40mg inj vials
0803043Q0AAAEAE
|
Pasireotide | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Pasireotide 600micrograms/1ml inj ampoules
0803043Q0AAABAB
|
Pasireotide | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Pasireotide 60mg inj vials
0803043Q0AAAFAF
|
Pasireotide | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Pasireotide 900micrograms/1ml inj ampoules
0803043Q0AAACAC
|
Pasireotide | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Signifor 0.3mg/1ml solution for injection ampoules
0803043Q0BBAAAA
|
Signifor | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Signifor 0.6mg/1ml solution for injection ampoules
0803043Q0BBABAB
|
Signifor | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Signifor 0.9mg/1ml solution for injection ampoules
0803043Q0BBACAC
|
Signifor | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Signifor 10mg inj vials
0803043Q0BBAGAG
|
Signifor | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Signifor 20mg inj vials
0803043Q0BBADAD
|
Signifor | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Signifor 30mg inj vials
0803043Q0BBAHAH
|
Signifor | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Signifor 40mg inj vials
0803043Q0BBAEAE
|
Signifor | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Signifor 60mg inj vials
0803043Q0BBAFAF
|
Signifor | Pasireotide | Malignant Disease and Immunosuppression | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.